Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Xenon Pharmaceuticals Inc. (XENE)

NASDAQ

$59.74

$-0.68

(-1.13%)

Previous Close: ⁦$60.40⁩

Market Closed

Xenon Pharmaceuticals Inc. (XENE) Live Price Chart

Last updated: ⁦2026-09-07 18:16:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Xenon Pharmaceuticals Inc. (XENE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $59.74, with a market capitalisation of $5.79B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $35.60 to $72.66. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.79B
Open	$60.02
Day's High	$72.66
Day's Low	$2.10
Previous Close	$60.40
Volume	343.55K
Average Volume	1.15M
P/E Ratio	--
52-Week High	$72.66
52-Week Low	$35.60
Dividend Yield	--
Earnings Date	--

Xenon Pharmaceuticals Inc. (XENE) Latest Closing Stock Price

Xenon Pharmaceuticals Inc. (XENE) last closed at $60.40 as of 2026-09-05 00:00:00, unchanged from the previous close of $60.40.

During the latest regular trading session, XENE traded between $2.10 and $72.66, with a volume of 343.55K shares. The closing price was near the upper end and near the middle of its 52-week range.

Xenon Pharmaceuticals Inc. (XENE) 7-Day Stock Price Change

Over the past seven days, Xenon Pharmaceuticals Inc. (XENE) moved from $61.93 to $59.74, representing a decline of 3.53% ($2.19).

The stock traded between $59.22 and $63.78 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 559.22 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

XENE 52-Week Price Position

Position in Range: 65.1%

52W Low$35.60

52W High$72.66

XENE is currently trading at $59.74, placing it 65.1% of the way from its 52-week low of $35.60 to its 52-week high of $72.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Xenon Pharmaceuticals Inc. (XENE)?

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	370
Exchange	NASDAQ
Company Website	https://www.xenon-pharma.com

How to Buy Xenon Pharmaceuticals Inc. (XENE) Stock on MEXC

Eligible investors can buy real shares of Xenon Pharmaceuticals Inc. (XENE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XENE and Place Your Order

Open the RealStocks trading page and search for XENE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Xenon Pharmaceuticals Inc. (XENE) share price today?

Xenon Pharmaceuticals Inc. (XENE) is currently trading at $ 59.74, down 1.09% ($0.66) from the previous close of $ 60.40. Intraday prices update in real time during regular trading hours.

2.Is XENE stock going up or down today?

As of 2026-09-05 00:00:00, XENE is trading at $ 59.74, down 1.09% ($0.66) from its previous close of $ 60.40. The stock has traded between $ 2.10 and $ 72.66 during today’s regular session. Past price movements do not guarantee future results.

3.What is XENE pre-market price?

As of 2026-09-05 00:00:00, XENE is trading at $ 60.70 in pre-market trading, up 0.49% ($0.30) from the previous close of $ 60.40. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XENE after-hours price?

As of 2026-09-05 00:00:00, XENE is trading at $ 59.97 in after-hours trading, down 0.72% ($0.43) from the regular-session close of $ 60.40. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is XENE stock trading now?

XENE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XENE sit relative to its 52-week high and low?

Over the past 52 weeks, XENE has traded between a low of $ 35.60 and a high of $ 72.66. At $ 59.74, the stock is positioned 65.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Xenon Pharmaceuticals Inc. in?

Xenon Pharmaceuticals Inc. (XENE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Xenon Pharmaceuticals Inc.'s market capitalisation and where is it listed?

Xenon Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 5.79B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XENE valued in terms of P/E ratio and EPS?

XENE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.23. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Xenon Pharmaceuticals Inc. pay a dividend?

Xenon Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.